RESEARCH TRIANGLE PARK, NC, Nov. 5, 2020 — Pappas Capital, a leading venture capital firm focused on advancing life sciences, today announced that its portfolio company, VelosBio Inc. (“VelosBio” or the...
Plexxikon Gets $15M Investment For Diabetes Drug Development (BioWorld Today)
News | 05. 27. 2004
Plexxikon
Plexxikon Inc. raised $15 million in venture financing to complete a Series B extension round.
